The Global Veterinary Diagnostics Market was valued at USD 5.3 billion in 2025 and is estimated to grow at a CAGR of 9.1% to reach USD 12.6 billion by 2035.
Market expansion is driven by the rising incidence of infectious, zoonotic, and chronic diseases across both companion and livestock animal populations, along with growing awareness of preventive veterinary healthcare. The increasing frequency of disease outbreaks continues to reinforce the need for accurate and rapid diagnostic solutions. Over recent years, the market has shown consistent growth, supported by higher expenditure on companion animal healthcare and continuous advancements in diagnostic technologies. The growing burden of emerging and transboundary animal diseases is further accelerating demand for reliable testing solutions. Rising global populations of companion animals and production livestock are also strengthening overall market demand. Pet ownership is increasing steadily, particularly for dogs and cats, while owners are showing greater willingness to invest in routine wellness screening and preventive care. At the same time, technological progress in molecular diagnostics, PCR-based methods, next-generation sequencing, biomarker assays, and portable point-of-care systems is improving the speed, precision, and accessibility of disease detection.
The consumables segment accounted for a 51.3% share in 2025 and continues to grow at a CAGR of 9.2% during 2026-2035. This dominance is driven by its essential role across diagnostic workflows and its recurring revenue structure. Consumables include reagents, diagnostic kits, assay cartridges, blood collection tubes, slides, calibration tools, and control materials, which are widely used across veterinary hospitals, clinics, diagnostic laboratories, and research centers.
The lab-based testing segment is projected to reach USD 7.1 billion by 2035. This segment remains widely preferred due to its ability to support advanced diagnostic procedures, including molecular testing, microbiological analysis, immunoassays, toxicology screening, and specialized pathology evaluations. These tests require advanced laboratory infrastructure, skilled professionals, and controlled environments to ensure high accuracy and reliability in disease detection.
North America Veterinary Diagnostics Market held 46.5% share in 2025. The region’s dominance is supported by advanced veterinary healthcare infrastructure, high pet ownership levels, strong diagnostic adoption rates, and widespread use of innovative animal health technologies. The presence of established diagnostic companies, extensive laboratory networks, and well-developed veterinary care systems further reinforces regional market strength and sustained growth.
Key industry participants include Zoetis, IDEXX Laboratories, bioMérieux, Bio-Rad Laboratories, Thermo Fisher Scientific, Neogen, QIAGEN, Virbac, Randox Laboratories, Fujifilm, Mindray Animal Medical Technology, BioNote, IDvet, INDICAL Bioscience, MEGACOR Diagnostik, Eurolyser Diagnostica, Agrolabo, Biochek, and GD Animal Health (Royal GD). Companies in the veterinary diagnostics market are strengthening their market position by focusing on continuous innovation in diagnostic technologies that improve the speed, accuracy, and reliability of test results. Many players are expanding their portfolios with advanced molecular diagnostics, multiplex testing platforms, and automated laboratory systems. Strategic collaborations with veterinary clinics, hospitals, and diagnostic laboratories are helping companies improve distribution reach and service integration. Firms are also investing heavily in research and development to introduce next-generation sequencing, biomarker-based assays, and portable diagnostic solutions. Expansion into emerging markets with growing pet populations and livestock industries is another key focus area.
This product will be delivered within 2-4 business days.
Market expansion is driven by the rising incidence of infectious, zoonotic, and chronic diseases across both companion and livestock animal populations, along with growing awareness of preventive veterinary healthcare. The increasing frequency of disease outbreaks continues to reinforce the need for accurate and rapid diagnostic solutions. Over recent years, the market has shown consistent growth, supported by higher expenditure on companion animal healthcare and continuous advancements in diagnostic technologies. The growing burden of emerging and transboundary animal diseases is further accelerating demand for reliable testing solutions. Rising global populations of companion animals and production livestock are also strengthening overall market demand. Pet ownership is increasing steadily, particularly for dogs and cats, while owners are showing greater willingness to invest in routine wellness screening and preventive care. At the same time, technological progress in molecular diagnostics, PCR-based methods, next-generation sequencing, biomarker assays, and portable point-of-care systems is improving the speed, precision, and accessibility of disease detection.
The consumables segment accounted for a 51.3% share in 2025 and continues to grow at a CAGR of 9.2% during 2026-2035. This dominance is driven by its essential role across diagnostic workflows and its recurring revenue structure. Consumables include reagents, diagnostic kits, assay cartridges, blood collection tubes, slides, calibration tools, and control materials, which are widely used across veterinary hospitals, clinics, diagnostic laboratories, and research centers.
The lab-based testing segment is projected to reach USD 7.1 billion by 2035. This segment remains widely preferred due to its ability to support advanced diagnostic procedures, including molecular testing, microbiological analysis, immunoassays, toxicology screening, and specialized pathology evaluations. These tests require advanced laboratory infrastructure, skilled professionals, and controlled environments to ensure high accuracy and reliability in disease detection.
North America Veterinary Diagnostics Market held 46.5% share in 2025. The region’s dominance is supported by advanced veterinary healthcare infrastructure, high pet ownership levels, strong diagnostic adoption rates, and widespread use of innovative animal health technologies. The presence of established diagnostic companies, extensive laboratory networks, and well-developed veterinary care systems further reinforces regional market strength and sustained growth.
Key industry participants include Zoetis, IDEXX Laboratories, bioMérieux, Bio-Rad Laboratories, Thermo Fisher Scientific, Neogen, QIAGEN, Virbac, Randox Laboratories, Fujifilm, Mindray Animal Medical Technology, BioNote, IDvet, INDICAL Bioscience, MEGACOR Diagnostik, Eurolyser Diagnostica, Agrolabo, Biochek, and GD Animal Health (Royal GD). Companies in the veterinary diagnostics market are strengthening their market position by focusing on continuous innovation in diagnostic technologies that improve the speed, accuracy, and reliability of test results. Many players are expanding their portfolios with advanced molecular diagnostics, multiplex testing platforms, and automated laboratory systems. Strategic collaborations with veterinary clinics, hospitals, and diagnostic laboratories are helping companies improve distribution reach and service integration. Firms are also investing heavily in research and development to introduce next-generation sequencing, biomarker-based assays, and portable diagnostic solutions. Expansion into emerging markets with growing pet populations and livestock industries is another key focus area.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Product, 2022-2035 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Modality, 2022-2035 ($ Mn)
Chapter 7 Market Estimates and Forecast, by Technology, 2022-2035 ($ Mn)
Chapter 8 Market Estimates and Forecast, by Application, 2022-2035 ($ Mn)
Chapter 9 Market Estimates and Forecast, by Animal Type, 2022-2035 ($ Mn)
Chapter 10 Market Estimates and Forecast, by End Use, 2022-2035 ($ Mn)
Chapter 11 Market Estimates and Forecast, by Region, 2022-2035 ($ Mn)
Chapter 12 Company Profiles
Companies Mentioned
- Agrolabo
- Bio-Rad Laboratories
- bioMerieux
- BioNote
- Biochek
- Eurolyser Diagnostica
- Fujifilm
- GD Animal Health (Royal GD)
- IDEXX Laboratories
- IDvet
- INDICAL Bioscience
- MEGACOR Diagnostik
- Mindray Animal Medical Technology
- Neogen
- QIAGEN
- Randox Laboratories
- Thermo Fisher Scientific
- Virbac
- Zoetis
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 130 |
| Published | June 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 5.3 Billion |
| Forecasted Market Value ( USD | $ 12.6 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 19 |
